Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: A Gynecologic Oncology Group study

Oncology Group ◽

Stage Iiic ◽

Should stage IIIC ovarian cancer be further stratified by intraperitoneal versus retroperitoneal-only disease? A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.12.036 ◽

2011 ◽

Vol 120 ◽

pp. S13-S14

Author(s):

B. Rungruang ◽

A. Miller ◽

S. Richard ◽

C. Hamilton ◽

N. Rodriguez ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Stage Iiic ◽

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.02.014 ◽

2006 ◽

Vol 101 (3) ◽

pp. 390-397 ◽

Cited By ~ 26

Author(s):

Angeles Alvarez Secord ◽

Paula S. Lee ◽

Kathleen M. Darcy ◽

Laura J. Havrilesky ◽

Lisa A. Grace ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Poor Prognosis ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Maspin Expression

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)

BMC Cancer ◽

10.1186/s12885-019-5514-7 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 4

Author(s):

Young Shin Chung ◽

Sang-Yoon Park ◽

Jung-Yun Lee ◽

Jeong-Yeol Park ◽

Jeong-Won Lee ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Gynecologic Oncology ◽

Serous Carcinoma ◽

High Grade ◽

Advanced Stage ◽

Oncology Group ◽

An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: A Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION

Annals of Oncology ◽

10.1093/annonc/mdz250.069 ◽

2019 ◽

Vol 30 ◽

pp. v432

Author(s):

J.-Y. Lee ◽

J.W. Kim ◽

B.G. Kim ◽

S. Kim ◽

H.S. Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Targeted Therapy ◽

Gynecologic Oncology ◽

Recurrent Ovarian Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Platinum Resistant

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2000.5755 ◽

2000 ◽

Vol 77 (1) ◽

pp. 112-115 ◽

Cited By ~ 30

Author(s):

Maurie Markman ◽

John A. Blessing ◽

Ronald D. Alvarez ◽

Parviz Hanjani ◽

Steven Waggoner ◽

...

Keyword(s):

Ovarian Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Platinum Sensitive

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2004.05.033 ◽

2004 ◽

Vol 94 (2) ◽

pp. 368-374 ◽

Cited By ~ 40

Author(s):

David H Moore ◽

James T Kauderer ◽

Jeffrey Bell ◽

John P Curtin ◽

Linda Van Le

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Alternative Treatments ◽

Oncology Group Study ◽

Factors Influencing

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.01.008 ◽

2012 ◽

Vol 125 (2) ◽

pp. 421-426 ◽

Cited By ~ 32

Author(s):

Jennifer M. Rubatt ◽

Kathleen M. Darcy ◽

Chunqiao Tian ◽

Franco Muggia ◽

Rajiv Dhir ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Clinical Outcomes ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Oncology Group Study ◽

Pre Treatment ◽

Tumor Expression

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study

Journal of Pain and Symptom Management ◽

10.1016/j.jpainsymman.2009.09.022 ◽

2010 ◽

Vol 39 (5) ◽

pp. 839-846 ◽

Cited By ~ 25

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Gibbons ◽

Bradley J. Monk ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Cancer Patients ◽

Gynecologic Oncology ◽

Life Domains ◽

Oncology Group ◽

Clinical Factors ◽

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A gynecologic oncology group study

International Journal of Gynecology & Obstetrics ◽

10.1016/0020-7292(91)90782-z ◽

1991 ◽

Vol 36 (2) ◽

pp. 170-170

Author(s):

W.T. Creasman ◽

G.A. Omura ◽

M.F. Brady ◽

E. Yordan ◽

P.J. DiSaia ◽

...

Keyword(s):

Ovarian Cancer ◽

Randomized Trial ◽

Gynecologic Oncology ◽

Stage Iii ◽

Bacillus Calmette Guerin ◽

Oncology Group ◽

Psychometric Evaluation of Two Scales Assessing Functional Status and Peripheral Neuropathy Associated With Chemotherapy for Ovarian Cancer: A Gynecologic Oncology Group Study

Oncology Nursing Forum ◽

10.1188/04.onf.615-623 ◽

2004 ◽

Vol 31 (3) ◽

pp. 615-623 ◽

Cited By ~ 43

Author(s):

Lois Almadrones ◽

Deborah B. McGuire ◽

Janet Ruth Walczak ◽

Colleen M. Florio ◽

Chunqiao Tian

Keyword(s):

Ovarian Cancer ◽

Peripheral Neuropathy ◽

Functional Status ◽

Gynecologic Oncology ◽

Psychometric Evaluation ◽

Oncology Group ◽